The tumor-specific marker genes (i.e. EPCAM, KRT8, EPCAM, B2M, FCA1 and KRT19) were also highly expressed in the tumor regions of prostate, colorectal, liver cancer, pancreas and breast cancer. This evidence concerns the gene EPCAM and breast cancer.